These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28694232)

  • 21. Impact of a Carbapenem Antimicrobial Stewardship Program on Patient Outcomes.
    Seah VXF; Ong RYL; Lim ASY; Chong CY; Tan NWH; Thoon KC
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28717037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens.
    Poulakou G; Bassetti M; Righi E; Dimopoulos G
    Future Microbiol; 2014; 9(9):1053-69. PubMed ID: 25340835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial-resistant Gram-negative infections in neonates: burden of disease and challenges in treatment.
    Folgori L; Bielicki J; Heath PT; Sharland M
    Curr Opin Infect Dis; 2017 Jun; 30(3):281-288. PubMed ID: 28306563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.
    Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V
    Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical assessment of colistin in treating infections caused by multidrug-resistant gram-negative bacillus in patients with severe burn].
    Zhang JP; Yang XS; Chen J; Peng YZ; Huang YS
    Zhonghua Shao Shang Za Zhi; 2009 Oct; 25(5):372-6. PubMed ID: 19951562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fosfomycin for the treatment of resistant gram-negative bacterial infections. Insights from the Society of Infectious Diseases Pharmacists.
    Reffert JL; Smith WJ
    Pharmacotherapy; 2014 Aug; 34(8):845-57. PubMed ID: 24782335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New information about the polymyxin/colistin class of antibiotics.
    Molina J; Cordero E; Pachón J
    Expert Opin Pharmacother; 2009 Dec; 10(17):2811-28. PubMed ID: 19929704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antimicrobial activity of "last-resort" antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates.
    Jacquier H; Le Monnier A; Carbonnelle E; Corvec S; Illiaquer M; Bille E; Zahar JR; Jauréguy F; Fihman V; Tankovic J; Cattoir V;
    Microb Drug Resist; 2012 Aug; 18(4):396-401. PubMed ID: 22335615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fosfomycin in infections caused by multidrug-resistant Gram-negative pathogens.
    Ruiz Ramos J; Salavert Lletí M
    Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):45-54. PubMed ID: 31131592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.
    Khan IU; Mirza IA; Ikram A; Ali S; Hussain A; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):914-7. PubMed ID: 25523727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin.
    Falagas ME; Maraki S; Karageorgopoulos DE; Kastoris AC; Mavromanolakis E; Samonis G
    Int J Antimicrob Agents; 2010 Mar; 35(3):240-3. PubMed ID: 20034765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The One Health stewardship of colistin as an antibiotic of last resort for human health in South Africa.
    Mendelson M; Brink A; Gouws J; Mbelle N; Naidoo V; Pople T; Schellack N; van Vuuren M; Rees H;
    Lancet Infect Dis; 2018 Sep; 18(9):e288-e294. PubMed ID: 29673734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies.
    Falagas ME; Roussos N; Gkegkes ID; Rafailidis PI; Karageorgopoulos DE
    Expert Opin Investig Drugs; 2009 Jul; 18(7):921-44. PubMed ID: 19548851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Old antibiotics for multidrug-resistant pathogens: from in vitro activity to clinical outcomes.
    Kaye KS; Gales AC; Dubourg G
    Int J Antimicrob Agents; 2017 May; 49(5):542-548. PubMed ID: 28130072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
    Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
    J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
    Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP
    World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin.
    Giske CG
    Clin Microbiol Infect; 2015 Oct; 21(10):899-905. PubMed ID: 26027916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R; Noriega ER; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.
    Falagas ME; Rafailidis PI; Ioannidou E; Alexiou VG; Matthaiou DK; Karageorgopoulos DE; Kapaskelis A; Nikita D; Michalopoulos A
    Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.